您当前的位置:
GLP-2 (human)
肠上皮特异性生长因子,GLP-2(1-33) (human) 是一种肠内分泌激素可已与GLP-2 受体结合并且刺激肠上皮细胞生长。
目录号: PC10892 纯度: ≥98%
CAS No. :223460-79-5
商品编号 规格 价格 会员价 是否有货 数量
PC10892-500ug 500ug ¥1764.00 请登录
PC10892-1mg 1mg ¥2940.00 请登录
PC10892-5mg 5mg ¥11172.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
GLP-2 (human)
中文别名
GLP-2 (HUMAN);人GLP-2肽
英文名称
GLP-2 (human)
英文别名
1-33-Glucagon-likepeptide II (human) (9CI);GLP-2 (1-33) (human);GLP-2 (1-33) (human) ,Preproglucagon (146-178) (human);GLP-2 (HUMAN);Glucagon-Like Peptide II, human;Glucagon-like peptide 2 (human);HADGSFSDEMNTILDNLAARDFINWLIQTKITD;0825W549JC;GLP-2(1-33)(human)
Cas No.
223460-79-5
分子式
C165H254N44O55S
分子量
3766.11
包装储存

Sealed storage, away from moisture and light

Powder -80°C 2 years
-20°C 1 year

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)

生物活性

GLP-2(1-33) (human) is an enteroendocrine hormone which can bind to the GLP-2 receptor and stimulate the growth of intestinal epithelium.

性状

Solid

IC50 & Target[1][2]

GLP-2 receptor

体外研究(In Vitro)

GLP-2-treated group demonstrates a 518±22% increase (P<0.05) in mucosal IGFBP-4 mRNA levels as compare with vehicle-treated controls. Because the mucosal expression of IGFBP-4 transcripts is found to be very low relative to that of the whole intestine, FRIC cultures are used as an 体外研究 model of the entire intestine. FRIC cultures have previously been established to express a functional GLP-2 receptor (GLP-2R) that displays a cAMP response, as well as enhances IGF-1 mRNA expression and IGF-1 secretion in response to GLP-2 treatment. When incubates with GLP-2 (10 M) for 2 hours, IGFBP-4 mRNA expression in the FRIC cultures is also found to be increased, by 40.8±15.2% (P<0.05), compare with vehicle-treated cells.

Medlife has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究(In Vivo)

GLP-2 quickly increases apoB48 mass in the TRL fraction of plasma, which is indicative of chylomicron number, and this is blocked by L-NAME. GLP-2 treatment alone increases postprandial TRL-lipids (slope 3.65±0.73×10 g/L/min vs 1.63±0.28×10 g/L/min, GLP-2 vs control), and this effect is completely mitigated by L-NAME pretreatment (slope 3.67±0.15×10 g/L/min). The GLP-2-induced rise in TRL-apoB48 occurres within 30 minutes and precedes the rise in TRL-TG. GLP-2 acutely increases plasma tritium levels (slope, 1.66±0.25×10 dpm/mL/min vs 1.11±0.17×10 dpm/mL/min, GLP-2 vs control).

Medlife has not independently confirmed the accuracy of these methods. They are for reference only.

运输条件

Room temperature or refrigerated transportation.

储存方式

Sealed storage, away from moisture and light

Powder -80°C 2 years
-20°C 1 year

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)

SequenceShortening

HADGSFSDEMNTILDNLAARDFINWLIQTKITD

Sequence

His-Ala-Asp-Gly-Ser-Phe-Ser-Asp-Glu-Met-Asn-Thr-Ile-Leu-Asp-Asn-Leu-Ala-Ala-Arg-Asp-Phe-Ile-Asn-Trp-Leu-Ile-Gln-Thr-Lys-Ile-Thr-Asp

参考文献
溶解度数据
体外研究: 

H2O : 25 mg/mL (6.64 mM; ultrasonic and adjust pH to 9 with NH4OH)

配制储备溶液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 0.2655 mL 1.3276 mL 2.6552 mL
5 mM 0.0531 mL 0.2655 mL 0.5310 mL
10 mM --- --- ---
*

产品不同,其溶解度不同。建议根据产品选择合适的溶剂配制储备溶液;配成溶液后,建议分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)。-80°C 储存时,建议在 6 个月内使用,-20°C 储存时,建议在 1 个月内使用。

搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2